Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder that affects the blood vessels. A person with HHT may have blood vessels that have not developed properly and may have no ...

Purpose: Hereditary hemorrhagic telangiectasia is an autosomal dominant disorder characterized by arteriovenous malformations (AVM), mostly cutaneous and mucous (telangiectases), but also involving ...

AUGUSTA, Ga. - A cancer drug that helps keep tumors from growing blood vessels may help patients with a rare genetic condition in which malformed vessels increase their risk for bleeding and anemia.

People with HHT have a near-typical life expectancy as long as they follow their treatment plan and undergo regular screening for complications. Hereditary hemorrhagic telangiectasia (HHT) is a rare ...

Medical imaging, like MRI, CT, and ultrasound, plays a vital role in diagnosing HHT, formerly known as Osler-Weber-Rendu syndrome. Imaging can help guide treatment and improve your outlook with HHT.

Patients with hereditary hemorrhagic telangiectasia (HHT), a rare genetic disorder that causes abnormal blood vessel formation, wage a lifelong battle against skin lesions, frequent nosebleeds and ...

Arteriovenous malformations, a hallmark of hereditary hemorrhagic telangiectasia, may be driven by endothelial cell-cycle acceleration via CDK6, suggesting potential for repurposing CDK6 inhibitors.

When Harper Ryals turned 2, she hit a growth spurt. But her mom, Rebecca Newman, noticed something unusual with her daughter’s growth — Harper’s fingertips had turned blue. “She got really big really ...